Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

Scientists suspected exenatide could help combat the condition ... However, they noted that unwanted weight-loss is a potential side-effect for patients of a healthy weight. About 150,000 people ...

Objective: This study evaluated the ability of the incretin mimetic exenatide (exendin-4) to improve glycemic control in patients with type 2 diabetes failing maximally effective doses of a ...

Earlier, two small studies suggested that exenatide may slow the progression ... barrier better than other GLP-1 drugs. However, side effects were common—46% experienced nausea, 13% had vomiting ...